ライフサイエンスコーパス: opportunistic infection

1 there were no episodes of acute rejection or opportunistic infection.

2 esult of infection during treatment; one had opportunistic infection.

3 associated with NeuroAIDS in the context of opportunistic infection.

4 associated with an increased risk of serious opportunistic infection.

5 d commonly lead to end-organ dysfunction and opportunistic infection.

6 s yielded an OR of 14.5 (95% CI, 4.9-43) for opportunistic infection.

7 No patient died from opportunistic infection.

8 dually with significantly increased odds for opportunistic infection.

9 and humoral immunity and protection against opportunistic infection.

10 es gammadeltaT cell-mediated protection from opportunistic infection.

11 ion, perturbation of immune-cell subsets and opportunistic infections.

12 eir interplay with other immune cells during opportunistic infections.

13 making sufferers vulnerable to all manner of opportunistic infections.

14 e diagnosis and management of HIV-associated opportunistic infections.

15 clinical or laboratory evidence, or both, of opportunistic infections.

16 f 57 HIV-infected individuals without ocular opportunistic infections.

17 Fungal pathogens are a frequent cause of opportunistic infections.

18 ights into tuberculosis, HIV/AIDS, and other opportunistic infections.

19 control GVHD and increase susceptibility to opportunistic infections.

20 nt differences in terms of the occurrence of opportunistic infections.

21 s and, presumably, susceptibility to certain opportunistic infections.

22 revent and treat HIV-1 infection and related opportunistic infections.

23 recovery, resulting in an increased risk of opportunistic infections.

24 SCT) is limited by patient susceptibility to opportunistic infections.

25 CD4(+) T lymphocytes and the development of opportunistic infections.

26 ell immune deficiency, and susceptibility to opportunistic infections.

27 s a pathogenic fungus responsible for severe opportunistic infections.

28 identified 100 consecutive IBD patients with opportunistic infections.

29 cterial infections were the major presenting opportunistic infections.

30 Similarly, treatment has reduced CNS opportunistic infections.

31 ly thought to predispose the injured host to opportunistic infections.

32 the mucosal immune system to control various opportunistic infections.

33 ow T-cell reconstitution, and a high risk of opportunistic infections.

34 er age are associated with increased risk of opportunistic infections.

35 g to increased risks of fatal posttransplant opportunistic infections.

36 ing the entire flora leaves patients open to opportunistic infections.

37 n skin and are implicated in a wide range of opportunistic infections.

38 cipally graft-versus-host disease (GVHD) and opportunistic infections.

39 ociated risk of viral reactivation and other opportunistic infections.

40 by severe SIV enteropathy in the absence of opportunistic infections.

41 omen not using cotrimoxazole prophylaxis for opportunistic infections.

42 both the failing immune system and recurrent opportunistic infections.

43 ystem, recipients are at increased risk from opportunistic infections.

44 rvival in extra-intestinal sites and promote opportunistic infections.

45 ional immunity to prevent transplant-related opportunistic infections.

46 y represent a therapeutic target for chronic opportunistic infections.

47 , and daily co-trimoxazole for prevention of opportunistic infections.

48 nfrequently associated with human and animal opportunistic infections.

49 virus type 1 coinfection without documented opportunistic infections.

50 iciency virus (HIV)-exposed infants to avoid opportunistic infections.

51 immune system, including disorders involving opportunistic infections.

52 D4(+) T-cell counts that can lead to serious opportunistic infections.

53 s regarding rejection, graft loss, death, or opportunistic infections.

54 ts in increased susceptibility to secondary (opportunistic) infections.

55 ction and 4 during open-label therapy) and 3 opportunistic infections (1 in each group during double-

56 re lymphopenia (82%), neutropenia (47%), and opportunistic infections (13%).

57 ociated vasculopathy (24 [38%]), followed by opportunistic infections (16 [25%]).

58 s, 2 cases of tuberculosis, 2 cases of other opportunistic infections, 3 cardiovascular events, and 4

59 ose for patients with AIDS without an ocular opportunistic infection (4.1 deaths/100 PY); toxoplasmic

60 Of 1825 participants with AIDS and no ocular opportunistic infections, 9.9% had intermediate-stage AM

61 reflects pathogenic immune responses against opportunistic infections acquired during the period of i

62 Rates of acute rejection, opportunistic infections, adverse events, CMV UL97 ganci

63 Nocardiosis is a rare, life-threatening opportunistic infection, affecting 0.04% to 3.5% of pati

64 Cytomegalovirus (CMV) is the most prevalent opportunistic infection after lung transplantation.

65 Cytomegalovirus (CMV) is a common opportunistic infection after solid organ transplantatio

66 Cytomegalovirus (CMV) is the most common opportunistic infection after solid-organ transplant.

67 both vaccine efficacy and protection against opportunistic infections after HSCT.

68 Cytomegalovirus (CMV) retinitis is a common opportunistic infection among patients with AIDS and sti

69 The most common opportunistic infections among children with JIA were 3

70 (HIV) disease under ineffective treatment of opportunistic infection and antiretroviral therapy (ART)

71 protect an immunocompromised host against an opportunistic infection and can be extended to other mic

72 e periphery are tightly regulated to prevent opportunistic infections and aberrant inflammation.

73 killer (NK)-cell lymphopenia associated with opportunistic infections and cancers.

74 been based on clinical indications, such as opportunistic infections and CD4 cell counts.

75 r special populations and in the settings of opportunistic infections and concomitant conditions are

76 Opportunistic infections and deaths are less common amon

77 n human immunodeficiency virus (HIV)-related opportunistic infections and deaths in US youth, but bot

78 She developed respiratory failure and opportunistic infections and died.

79 oses the central nervous system to damage by opportunistic infections and environmental insults.

80 ICL predisposes patients to severe opportunistic infections and frequently leads to poor va

81 erpesvirus infections contribute to risk for opportunistic infections and graft rejection.

82 ICL confers an increased risk of opportunistic infections and has no established treatmen

83 ications such as increased susceptibility to opportunistic infections and inadequate healing of wound

84 depletion is linked directly to the risk for opportunistic infections and infection-associated mortal

85 has shifted from prevention and treatment of opportunistic infections and malignancies to management

86 uated both metrics as predictors of incident opportunistic infections and mortality.

87 on of affected infants before development of opportunistic infections and other complications.

88 that expose patients to an increased risk of opportunistic infections and other complications.

89 Other opportunistic infections and outcomes were not significa

90 cytokine release reactions; the incidence of opportunistic infections and second malignancies was sim

91 olism that contributes to increased rates of opportunistic infections and sepsis in alcoholics.

92 ated stigma, decreased CD4 levels, increased opportunistic infections and sociodemographic variables.

93 grin alphaMbeta2 or alphaXbeta2 to deal with opportunistic infections and the capacity of cells deriv

94 The prevalence of opportunistic infections and the mortality have decrease

95 nically relevant boost of immunity to reduce opportunistic infections and to increase graft-versus-le

96 The AIDS-defining opportunistic infections and tumors mark the end-point o

97 etected in 88% of Asian adults with multiple opportunistic infections and were associated with an adu

98 cells, leading to profound immunodeficiency, opportunistic infections, and eventually death.

99 mmune system dysfunction, a higher burden of opportunistic infections, and metabolic derangements.

100 T cells can enhance engraftment, counteract opportunistic infections, and mount graft-versus-tumor (

101 AIDS-related stigma, CD4 levels, presence of opportunistic infections, and sociodemographic variables

102 thogenic bacteria, control of gut-associated opportunistic infections, and survival of SIV-infected R

103 t of pulmonary alveolar proteinosis or other opportunistic infections, and that patients may benefit

104 tween adaptation to natural environments and opportunistic infections, and that selection on specific

105 ities, such as dyslipidemia, drug abuse, and opportunistic infections; and lifestyle are risk factors

106 ated CD4(+) T-cell response against residual opportunistic infection antigen.

107 HIV-associated vasculopathy and opportunistic infections are common causes of HIV-relate

108 Opportunistic infections are generally ascribed to defec

109 by the fact that the symptoms and associated opportunistic infections are highly varied.

110 Opportunistic infections are often polymicrobial.

111 ive and potent DHFR inhibitors against these opportunistic infections are presented.

112 Opportunistic infections are rare among children with JI

113 GVHD and opportunistic infections are the major risks associated

114 ection in humans leads to the development of opportunistic infections as well as increased rates of b

115 such as acute graft-versus-host disease and opportunistic infections, as the predominant causes of d

116 the commensal fungus Candida albicans, is an opportunistic infection associated with infancy, AIDS, a

117 Microsporidia, a latent opportunistic infection associated with mild inflammatio

118 an HIV infection, T cell exhaustion leads to opportunistic infections associated with AIDS.

119 In contrast to most other opportunistic infections associated with HIV, an increas

120 positive patients who did not have an ocular opportunistic infection at enrollment.

121 aluated data for participants without ocular opportunistic infections at initial examination (baselin

122 2) in the modern era, C. trachomatis causes "opportunistic" infection at non-GI sites under condition

123 kages with an increase in diseases including opportunistic infections, autoimmunity, and incidence/bu

124 severity of illness, only the presence of an opportunistic infection before hospital admission was in

125 AIDS Society, Conference on Retroviruses and Opportunistic Infections, between 1996 to May 2013.

126 amma are associated with severe disseminated opportunistic infection, but their importance and preval

127 Morphine increases the susceptibility to opportunistic infection by attenuating bacterial clearan

128 ion of these patients has led to the rise of opportunistic infections by organisms that are recalcitr

129 g enterobacteria may help human hosts resist opportunistic infections by Pseudomonas and other pyoche

130 Most opportunistic infections can be recognised by a combinat

131 Retinal opportunistic infections can occur in patients with aqua

132 opharyngeal candidiasis (OPC [thrush]) is an opportunistic infection caused by the commensal fungus C

133 Opportunistic infections caused by pathogens associated

134 ate, five NPs developed AIDS associated with opportunistic infections caused by Pneumocystis carinii,

135 Opportunistic infections caused by Pneumocystis jiroveci

136 iding clinical care to start prophylaxis for opportunistic infections, CD4 counts should cease to be

137 Opportunistic infections contribute to morbidity and mor

138 susceptibility of discordant patients toward opportunistic infections despite virological control.

139 Eight patients with GS had opportunistic infections, despite normal peripheral CD4(

140 for clinical outcomes after UCBT, including opportunistic infections, disease relapse, and overall s

141 s developing advanced disease and associated opportunistic infections due to a failure to effectively

142 Although opportunistic infections due to Mycobacterium avium comp

143 PML and another 343 who did not suffer this opportunistic infection during natalizumab treatment.

144 ributes to the protection of gut mucosa from opportunistic infections during the course of SIV infect

145 here were no treatment-related deaths or new opportunistic infections during treatment, and patients

146 Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosu

147 No patients in either group had opportunistic infections (excluding oral candidiasis and

148 Most studies of opportunistic infections focus on those with weak immune

149 sma gondii is a major food-borne illness and opportunistic infection for the immunosuppressed.

150 ter measles is known to predispose people to opportunistic infections for a period of several weeks t

151 mocystis carinii (PC) pneumonia is a leading opportunistic infection found among HIV-infected individ

152 se severity, CMV infection, acute rejection, opportunistic infections, ganciclovir resistance, and sa

153 Group for the Study of Kaposi's Sarcoma and Opportunistic infections (GHESKIO) Clinic in Port-au-Pri

154 sk of acute and chronic allograft rejection, opportunistic infection, graft failure, and patient mort

155 ttributable to viral reactivation (including opportunistic infection, graft rejection and severe hepa

156 l acquired immunodeficiency syndrome-related opportunistic infections has decreased with successful a

157 ve multifocal leukoencephalopathy, other CNS opportunistic infections have been rarely reported durin

158 ve antiretroviral drugs has markedly reduced opportunistic infections, HCV-related liver disease has

159 Unlike pathogens that establish opportunistic infections, hundreds of human commensal ba

160 T, specific antiretroviral drugs, history of opportunistic infection, immune status, or duration of a

161 reas Toxoplasma gondii is a life-threatening opportunistic infection in AIDS patients.

162 Overall, 15 (41.6%) developed an opportunistic infection in follow-up, 5 (13.8%) of which

163 n of oral mucosal tissue, is the most common opportunistic infection in HIV(+) and immunocompromised

164 ion, and risk of developing an AIDS-defining opportunistic infection in HIV-infected men.

165 tis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the

166 Tuberculosis (TB) is the most common opportunistic infection in human immunodeficiency virus

167 e against Fusarium spp., which represents an opportunistic infection in humans and plants.

168 The absolute risk of opportunistic infection in IBD patients remains to be de

169 Cytomegalovirus is the most common viral opportunistic infection in immunocompromised patients.

170 that causes cryptococcosis, which is a major opportunistic infection in immunosuppressed individuals.

171 r, pneumococcal pneumonia is the most common opportunistic infection in individuals with HAND.

172 ed that invasive aspergillosis, a prototypic opportunistic infection in neutropenic hosts, is associa

173 Cytomegalovirus (CMV) is a late-stage opportunistic infection in people living with human immu

174 -transplant tuberculosis (PTTB) is a serious opportunistic infection in renal graft recipients with a

175 Pneumocystis pneumonia remains a common opportunistic infection in the diverse immunosuppressed

176 al immunodeficiency and an increased risk of opportunistic infections in allogeneic bone marrow trans

177 Cryptococcus species are known agents of opportunistic infections in healthy and immunocompromise

178 n Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adol

179 Diagnosis of opportunistic infections in HIV-infected individuals rem

180 might have therapeutic potential to prevent opportunistic infections in HIV-infected patients.

181 d be important in susceptibility to specific opportunistic infections in HIV.

182 seudomonas aeruginosa, an important cause of opportunistic infections in humans, delivers bacterial c

183 asive environmental bacterium that can cause opportunistic infections in humans.

184 of warm-blooded vertebrates that also causes opportunistic infections in humans.

185 They also cause life-threatening opportunistic infections in immunocompromised individual

186 c Gram-negative bacterium that causes severe opportunistic infections in immunocompromised individual

187 osa is a Gram-negative bacterium that causes opportunistic infections in immunocompromised individual

188 ns, and the role of enteric microsporidia as opportunistic infections in immunodeficient people.

189 e clinical factors that were associated with opportunistic infections in inflammatory bowel disease p

190 tion could represent individuals with occult opportunistic infections in need of additional screening

191 dies may be important in the pathogenesis of opportunistic infections in patients with thymic maligna

192 gest to specifically include reactivated and opportunistic infections in the differential diagnosis o

193 , which is a major cause of life-threatening opportunistic infections in the immunocompromised host.

194 Opportunistic infections included viral in 15.3%, fungal

195 transplant (SOT) recipients are at risk for opportunistic infections including tuberculosis.

196 less, children with JIA had a higher rate of opportunistic infections, including an increased rate of

197 age niche that is associated with a range of opportunistic infections, including infectious endocardi

198 D40 ligand (CD40L) deficiency predisposes to opportunistic infections, including those caused by fung

199 The risk for HIV-associated opportunistic infections increases as circulating CD4+ l

200 y protocols that defined prophylaxis against opportunistic infection, indications for biopsy, and acc

201 This opportunistic infection is highly refractory to conventi

202 During HIV infection, the timing of opportunistic infections is not always associated with s

203 In the era of HAART, diarrhea from opportunistic infections is uncommon, and HIV-associated

204 d antiretroviral (ARV) drug use with risk of opportunistic infections, key clinical events, and morta

205 Opportunistic infections, long-term outcomes and the bur

206 e prophylaxis prolongs survival and prevents opportunistic infections, malaria, and diarrhea in perso

207 No cases of tuberculosis, opportunistic infections, malignancies, lymphomas, lupus

208 Strategies aimed at preventing this fatal opportunistic infection may improve outcomes.

209 Although uncommon, non-CMV ocular opportunistic infections may be associated with high rat

210 Besides HIV-1 itself, a number of opportunistic infections may cause renal disease in HIV-

211 By focusing on three common opportunistic infections (Mycobacterium tuberculosis, hu

212 es were mostly pneumonia (n = 157; 44.4%) or opportunistic infection (n = 76; 21.5%).

213 l candidiasis (OPC) is among the most common opportunistic infections observed in persons infected wi

214 Opportunistic infections occurred in 3 patients: 2 Pneum

215 Opportunistic infection of oligodendrocytes by human JC

216 ltifocal leukoencephalopathy (PML) is a rare opportunistic infection of the central nervous system.

217 lectin I (PA-IL), a key protein involved in opportunistic infections of P. aeruginosa , and mouse ma

218 ysiology and act as virulence factors during opportunistic infections of plant and animal hosts.

219 ilus influenzae (NTHI) is a leading cause of opportunistic infections of the respiratory tract in chi

220 py (ART) is initiated after an AIDS-defining opportunistic infection (OI) is uncertain and understudi

221 y-proven acute rejection (BPAR), graft loss, opportunistic infections (OI), new-onset diabetes after

222 must be closely monitored for development of opportunistic infections (OI), such as cytomegalovirus.

223 ar immunity and increasing susceptibility to opportunistic infections (OI).

224 ew recent data on the rates of AIDS-defining opportunistic infections (OIs) among human immunodeficie

225 Knowledge of central nervous system (CNS) opportunistic infections (OIs) among people living with

226 evaluate the incidence and prevalence of 14 opportunistic infections (OIs) and other infections as w

227 constitution and prolonged susceptibility to opportunistic infections (OIs) especially in patients un

228 retroviral therapy (ART) on incidence of key opportunistic infections (OIs) in human immunodeficiency

229 hs posttransplant and their correlation with opportunistic infections (OIs) in solid organ transplant

230 We aimed to review their association with opportunistic infections (OIs), including fungal, viral

231 was lowest in patients without a history of opportunistic infection or transfusions and who received

232 transplantation without an increased risk of opportunistic infections or cancer.

233 No opportunistic infections or deaths occurred.

234 ntrast sensitivity (in the absence of ocular opportunistic infections or media opacity), abnormalitie

235 units in either eye in the absence of ocular opportunistic infections or media opacity.

236 r of neurological symptoms in the absence of opportunistic infections or other co-morbidities, sugges

237 Excluding studies of opportunistic infections or prevention of mother-to-chil

238 xcellent survival for patients without prior opportunistic infections or transfusions and should be c

239 >10 years of age or those with a history of opportunistic infections or transfusions before HCT.

240 f biopsy-proven acute rejection, graft loss, opportunistic infections, or new-onset diabetes after tr

241 es out contagious transmission and indicates opportunistic infections originating from the environmen

242 symptoms of immunodeficiency and evidence of opportunistic infections (Pneumocystis, Candida, and Myc

243 sociations between putative risk factors and opportunistic infections, presented as odds ratios (OR)

244 enic burden with antimicrobial treatment for opportunistic infections prior to starting ART.

245 bacteria and viruses that essentially become opportunistic infections promoting systemic immune activ

246 ART with opportunistic infection prophylaxis enables the delivery

247 thoprim-sulfamethoxazole (TMP-SMX), used for opportunistic infection prophylaxis in HIV-exposed infan

248 and HIV-uninfected, HIV-exposed children as opportunistic infection prophylaxis.

249 cute lung injury, the presence of a previous opportunistic infection, rather than traditional measure

250 of aGVHD and cGVHD, low frequency of delayed opportunistic infections, reduced transfusion requiremen

251 tation were associated with adverse outcome (opportunistic infection-related death; P = .003 and .02,

252 the advances in antiretroviral therapy, CNS opportunistic infections remain a serious burden worldwi

253 There were no malignant neoplasms or opportunistic infections reported with BG-12.

254 Hematology patients with this opportunistic infection require integrated care across s

255 profound immune suppression, and consequent opportunistic infection results in high morbidity and mo

256 was a statistically significant predictor of opportunistic infection risk.

257 infection among atopic patients as caused by opportunistic infections secondary to airway inflammatio

258 All patients with opportunistic infection showed multiple anti-cytokine au

259 The ability to diagnose HIV and opportunistic infections simultaneously at the point of

260 onal models that excluded case patients with opportunistic infections, sTNFR-1, sCD27, and sCD40L wer

261 This results in susceptibility to an opportunistic infection such as Pneumocystis pneumonia.

262 cell dysfunctions causing susceptibility to opportunistic infections such as Pneumocystis murina pne

263 pha agents and serious infections, including opportunistic infections such as tuberculosis, in rheuma

264 in immunodeficiencies and susceptibility to opportunistic infections, such as Pneumocystis.

265 d lowers the incidence of diseases caused by opportunistic infections, such as tuberculosis (TB).

266 lier among patients with AIDS free of ocular opportunistic infections than in the general population.

267 ric disease; (ii) its emergence as a chronic opportunistic infection that complicates AIDS; (iii) ack

268 Cytomegalovirus (CMV) is the most prevalent opportunistic infection that occurs in lung-transplant r

269 stis pneumonia (PCP) is a potentially lethal opportunistic infection that primary prophylaxis can hel

270 Fungi are major contributors to the opportunistic infections that affect patients with HIV/A

271 mely common airway commensal which can cause opportunistic infections that are usually localized to a

272 nic rhinitis and increased susceptibility to opportunistic infections that causes the postnatal letha

273 ocused on the management of HIV/AIDS-related opportunistic infections that occur in the United States

274 ions from the Conference on Retroviruses and Opportunistic Infections, the International AIDS Society

275 reatments after burn injury protects against opportunistic infections through promotion of local and

276 gi range from commensal organisms that cause opportunistic infections to primary fungal pathogens tha

277 HIV-associated morbidity and mortality from opportunistic infections toward a variety of other medic

278 We defined 15 types of opportunistic infection using physician diagnosis or hos

279 in stroke via several mechanisms, including opportunistic infection, vasculopathy, cardioembolism, a

280 er nAPCsr, and a lower ETP, while history of opportunistic infection was associated with a higher nAP

281 Once an ocular opportunistic infection was diagnosed, patients were see

282 The relative risk of opportunistic infection was greatest in IBD patients see

283 ol, pack per year of smoking, and history of opportunistic infection were associated with baseline pl

284 d IBD patients who did not have a history of opportunistic infection were selected as controls.

285 The risks of nephrotoxic effects and opportunistic infection were similar for patients in the

286 In contrast, opportunistic infections were commonly observed in CP ma

287 When all opportunistic infections were considered together as a s

288 68 survivors, 7 second primary tumors and 8 opportunistic infections were diagnosed.

289 At enrollment, 37 non-CMV ocular opportunistic infections were diagnosed: 16 patients, he

290 Opportunistic infections were more frequent following FC

291 No opportunistic infections were noted, and only 3 infectio

292 as well as new strategies for prevention of opportunistic infections will aid in the future therapeu

293 In contrast, maternal co-opportunistic infection with primary or reactivated cyto

294 ified with regard to the risk of serious and opportunistic infections with biologic therapy.

295 In addition, opportunistic infections with Citrobacter species or Kle

296 y impair protective immunity against certain opportunistic infections with progression to AIDS.

297 ; Mycobacterium tuberculosis was the leading opportunistic infection, with more than half of patients

298 nfection (group 1); 45 patients with another opportunistic infection, with or without nontuberculous

299 Seven patients died, 4 from ICL-related opportunistic infections, within 42 months after diagnos

300 immunodeficiency virus (HIV) and associated opportunistic infections would be expected to decline.